Search Results - "Dayes, I."

A systematic review of axillary nodal irradiation for the management of the axilla in patients with early-stage breast cancer by Perera, F., Baldassarre, F.G., Eisen, A.F., Dayes, I., Engel, J., Cil, T., Kornecki, A., George, R., SenGupta, S., Brackstone, M.

“…Given numerous publications and clinical trials regarding axillary management in breast cancer, we sought to summarize this complex literature to help clarify…”
Get full text

Intensity-modulated Radiotherapy in the Treatment of Breast Cancer by Dayes, I, Rumble, R.B, Bowen, J, Dixon, P, Warde, P

“…Abstract Intensity-modulated radiotherapy (IMRT) is a newer method of radiotherapy that uses beams with multiple intensity levels for any single beam, allowing…”
Get full text

18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer by You, J J, Cline, K J, Gu, C-S, Pritchard, K I, Dayes, I S, Gulenchyn, K Y, Inculet, R I, Dhesy-Thind, S K, Freeman, M A, Chan, A M, Julian, J A, Levine, M N

“…Background: Sometimes the diagnosis of recurrent cancer in patients with a previous malignancy can be challenging. This prospective cohort study assessed the…”
Get full text

Locoregional therapy of locally advanced breast cancer: a clinical practice guideline by Brackstone, M, Fletcher, G G, Dayes, I S, Madarnas, Y, SenGupta, S K, Verma, S

“…In female patients with locally advanced breast cancer (labc) and good response to neoadjuvant chemotherapy (nact), including endocrine therapy, what is the…”
Get full text

Cardiac Sparing With Breath-hold Technique: A Dosimetric Evaluation of Benefits in Different Patient Populations by Lin, A, Kim, D, Sharieff, W, Szabo, J, Sussman, J, Dayes, I, Strang, B, Wright, J, Reiter, H, Whelan, T

Get full text

Electronic Web-based Technology Significantly Improves Quality of Life (QOL) Data Collection: Analysis of RTOG 0828 by Movsas, B, Hunt, D, Watkins-Burner, D, Lee, W.R, Tharpe, H, Goldstein, D, Moore, J, Dayes, I, Parise, S, Sandler, H

Get full text

Local tumour control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy : a meta-analysis by DAYES, I. S, ABUZALLOUF, S

“…The purpose of this paper was to estimate the effect of nitroimidazoles on the local control and overall survival of women receiving radiotherapy for carcinoma…”
Get full text

Influence of Gold Seed Implantation on Defining Target Volumes for Conformal Radiotherapy of Prostate Cancer by Pan, M, Lukka, H, Corbett, T, Patel, M, Tsakiridis, T, Dayes, I

Get full text

Quality of Life in Patients Enrolled in a Randomized Clinical Trial Evaluating Hypofractionated Radiotherapy for Intermediate Risk Prostate Cancer by Sanmamed, N.S., Chung, P., Dayes, I., Liu, A., Catton, C.N., Wright, J., Martin, J.M.

“…The PROFIT study was designed to evaluate hypofractionated (HF) radiotherapy versus conventional fractionation (CF) for patients with intermediate-risk…”
Get full text

Po‐Poster ‐ 29: Radiation‐induced apoptosis of lymphocytes to predict late toxicity from radiotherapy by Schnarr, K, Dayes, I, Sathya, J, McFarlane, N, Boreham, D

“…An important challenge arises in radiotherapy when certain individuals present with abnormal radiosensitivities. Radiosensitive individuals may not tolerate…”
Get full text

Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC) by Schep, D., Dayes, I., Lukka, H., Quan, K., Kapoor, A., Vansantvoort, J., Chow, T., Swaminath, A.

“…SABR has recently been proven to be a safe, effective treatment for RCC. However, long term follow-up assessment can be challenging as traditional methods of…”
Get full text

Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionation External Beam Radiotherapy (EBRT) Boost for Unfavorable Intermediate and High-Risk Prostate Cancer; Early Results of PBS: A Phase II Randomized Trial (NCT03380806) by Gouveia, A.G., Mesci, A., Isfahanian, N., Dayes, I., Quan, K., Goldberg, M., Schnarr, K.L., Lukka, H., Cuthbert, D., Hallock, A., Douvi, G., Wright, J., Swaminath, A., Chow, T., Diamond, K., Hajdok, G., Maharaj, L., Ewusive, J., Tsakiridis, T.

“…Treatment of high-risk (HR) prostate cancer (PC) usually involves pelvic conventional fractionation (CF)-EBRT, followed by CF-EBRT boost to prostate in…”
Get full text

Impact of Pelvic Intensity-modulated Radiotherapy (IMRT) on Lymph Node Coverage and Dose to Critical Organs, Compare to Three-Dimensional Conformal Radiation Therapy (3D-CRT), in Localized High-Risk Prostate Cancer by Isfahanian, N., Douvi, G., Arsenault, J., Dayes, I., Tolakanahalli, R.P., Lukka, H., Patel, M., Chow, T., Parpia, S., Tsakiridis, T.

Get full text

Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non-Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer by Lee, W.R., Dignam, J.J., Amin, M., Bruner, D.W., Low, D., Swanson, G.P., Shah, A.B., D'Souza, D.P., Michalski, J.M., Dayes, I., Seaward, S.A., Hall, W.A., Nguyen, P.L., Pisansky, T.M., Faria, S.L., Chen, Y., Rodgers, J., Sandler, H.M.

“…To assess whether the efficacy of a hypofractionated (H) schedule is no worse than a conventional (C) schedule in men with low-risk prostate cancer. Accrual…”
Get full text

Randomized Study of Quality of Life in Patients with High-Risk Prostate Cancer Undergoing Radiotherapy: Role of Pelvic Nodal IMRT by Arsenault, J., Parpia, S., Lukka, H., Corbett, T.B., Patel, M., Tsakiridis, T., Dayes, I.

Get full text

Baseline staging of newly diagnosed prostate cancer: a summary of the literature by Abuzallouf, Sadeq, Dayes, Ian, Lukka, Himu

“…Staging for prostate cancer often includes bone scanning and computerized tomography (CT). We systematically reviewed the published evidence for these tests…”
Get more information

Patient Reported Outcomes in NRG Oncology/RTOG 0938, a Randomized Phase II Study Evaluating 2 Ultrahypofractionated Regimens (UHR) for Prostate Cancer (CaP) by Lukka, H., Deshmukh, S., Bruner, D.W., Bahary, J.P., Lawton, C.A.F., Efstathiou, J.A., Kudchadker, R., Ponsky, L., Seaward, S.A., Dayes, I., Gopaul, D.D., Michalski, J.M., Delouya, G., Kaplan, I.D., Horwitz, E.M., Roach, M., Beyer, D.C., Sandler, H.M., Kachnic, L.A.

Get full text

183 Can an In Vitro Assay Predict Radiation Sensitivity in Patients with Carcinoma of the Prostate? by Dayes, I., Schnarr, K., Sathya, J., Julian, J., Boreham, D.

Get full text

An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival by Ung, Y., Gu, C., Cline, K., Sun, A., MacRae, R. M., Wright, J. R., Yu, E., Ehrlich, L., Gulenchyn, K. Y., Shulman, H., Dayes, I. S., Dhesy-Thind, S. K., Darling, G. E., Leighl, N. B., Evans, W. K., Julian, J. A., Levine, M. N.

“…Abstract only…”
Get full text

59 Radiation — Induced apoptosis of lymphocytes to predict normal tissue late toxicity from radiotherapy by Schnarr, K., Dayes, I., Sathya, J., McFarlane, N., Boreham, D.

Get full text